NKG2D signaling certifies effector CD8 T cells for memory formation
Cynthia Pérez(Loyola University Chicago), José A. Guevara-Patiño(Moffitt Cancer Center)
Cited by 32
Related Papers
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
|Cancer Research Communications|2023|14
Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab
|Cancer Immunology Immunotherapy|2025|10
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer
|Clinical Cancer Research|2025|3
Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic Transplantation
|Transplantation and Cellular Therapy|2025|1